AiSpeak
主要為改善語音和溝通，專注於發展聲門閉合不全的長期植入系統和構音障礙患者的語音轉換平台，提供構音障礙患者的語音轉換解決方案。

宇康生科為從事醫療器材開發的公司，由具跨國背景的醫生和矽谷工程師組成，並整合台灣在地人才，由臨床未滿足需求出發，提出創新的解決方案。產品包含解決發聲問題的長期喉部植入物(VOIS)及溝通障礙的軟體服務(AiSpeak)。AiSpeak結合大數據與電腦學習技術，可將構音障礙患者模糊不清的語音，即時辨識並轉換成能被理解的清晰語音，有效地提升患者的溝通能力與生活品質。宇康務實推動創新醫療產品商品化，以提供高品質醫材，創造產業價值為目標。

APrevent is a medical device company founded by a team of international experienced physician and engineer from silicon valley. APrevent is dedicated to providing minimally invasive long-term laryngeal implant (VOIS) and Software-as-a-Service technologies (AiSpeak) for voice and speech disorders. AiSpeak uses big data and AI machine learning technology helping patients to communicate with their own speech, which converts dysarthric speech into intelligible speech in real time. APrevent’s innovations are patient-oriented, physician friendly, and improve the quality of lives for patients around the world.